Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis

Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis: a Randomised Placebo-controlled Trial

Chronic Rhinosinusitis (CRS) is a chronic condition with limited therapeutic options. Moreover, the pathophysiology is poorly understood. The aim of this study is to evaluate the efficacy of osteopathic manipulative treatment (OMT) in the course of this condition by applying several techniques supposed to be related to the autonomic nervous system. Our hypothesis is that these techniques could have beneficial effects on inflammation and head symptoms in CRS.

Methods:

A sample of 90 patients diagnosed by ENT specialist will be randomly assigned to the OMT group or the placebo group. The placebo procedure will consist in using light touch around the nose, on the throat and on the thorax. Treatment and placebo protocols are composed of two visits at day 0 and day 30.

A general practitioner will determine the eligibility for the study.

The outcomes include Peak Nasal Inspiratory Flow (PNIF) measured five times: at day 0, 30 (twice each, before and after treatment) and 180 (once). The two groups will be compared regarding short and long term evolution.

The evolution of symptoms will be assessed by the Sino-nasal Outcome Test (SNOT-22) seven times: at day 0, 30, 60, 90, 120, 150 and 180. This outcome will be analyzed using mixed effect modelling

A Qualitative study will be conducted in the two groups to understand the patients' experiences during care.

This protocol has been approved by a french ethic committee (Comité de Protection des Personnes Sud Ouest et Outre-Mer II, 2020.04.09).

Study Overview

Detailed Description

Statistical analysis details:

PNIF middle term evolution:

If the two groups can be compared regarding their socio-demographics characteristics, a student's t-test will compare evolution (day 0 before treatment to day 30 before treatment) of the PNIF between groups.

If characteristics are different, a multivariate linear model will be applied.

PNIF long term evolution:

The same tests will be made. The evolution will be assessed between day 0 (before treatment) and day 180.

PNIF short term evolution:

The same tests will be made. The evolution will be assessed before and after treatment at day 0 and day 30.

SNOT-22 evolution:

Mixed effect model will assess the evolution of symptoms from day 0 to day 180

Response Shift detection:

For the SNOT-22, an Oort procedure will be performed in order to detect Response shift among individuals.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Le Mans, France, 72000
        • Cabinet ORL du Maine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age between 18 and 50
  • Chronic rhinosinusitis diagnosed by ear, nose, and throat (ENT) specialist or general practitioner
  • informed consent given
  • registered under french social security system

Exclusion Criteria:

  • contraindication to spine manipulation
  • receiving other treatment for CRS during this study
  • being pregnant
  • being under legal protection
  • withdrawal of consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo group

The osteopath will lay hands without movement on the nose, the throat and the thorax of patients.

This procedure takes around 15 minutes.

Experimental: OMT group

Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis.

This procedure takes around 15 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in peak nasal inspiratory flow (PNIF)
Time Frame: PNIF will be perform at day 0 (before treatment) and at day 30 (before treatment)
The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask.
PNIF will be perform at day 0 (before treatment) and at day 30 (before treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Sino-nasal Outcomes Test 22 (SNOT-22)
Time Frame: Patients will complete the questionnaire at baseline (day 0), day 30, day 60, day 90, day 120, day 150 and day 180 to assess the change over time
This is a symptom-based rhinosinusitis questionnaire. Possible total scores range from 0 to 110, where a higher score indicates worse symptoms.
Patients will complete the questionnaire at baseline (day 0), day 30, day 60, day 90, day 120, day 150 and day 180 to assess the change over time
Patient-reported experience of care
Time Frame: Interview will occur at day 180
Individual interviews will enable to document the personal experience during effective or placebo treatment.
Interview will occur at day 180
Sort term change in peak nasal inspiratory flow (PNIF)
Time Frame: PNIF will be perform at day 0 (before and after treatment), day 30 (before and after treatment)
The aim of this outcome is to measure change before and after each treatment in nasal airflow during maximal inspiration with a facial mask.
PNIF will be perform at day 0 (before and after treatment), day 30 (before and after treatment)
long term change in peak nasal inspiratory flow (PNIF)
Time Frame: PNIF will be perform at day 0 (before treatment) and at day 180.
The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask from base line to day 180.
PNIF will be perform at day 0 (before treatment) and at day 180.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: sebastien cambier, Institut des Hautes Etudes Osteopathiques de Nantes
  • Study Director: maxime salmon, MsC, Institut des Hautes Etudes Osteopathiques de Nantes
  • Study Chair: Marie Moreau, Institut des Hautes Etudes Osteopathiques de Nantes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2021

Primary Completion (Estimated)

June 1, 2022

Study Completion (Estimated)

June 30, 2022

Study Registration Dates

First Submitted

May 28, 2020

First Submitted That Met QC Criteria

June 3, 2020

First Posted (Actual)

June 9, 2020

Study Record Updates

Last Update Posted (Actual)

August 1, 2023

Last Update Submitted That Met QC Criteria

July 29, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Osteonose
  • 2019-A02907-50 (Other Identifier: Agence nationale de sécurité du médicament et produits de santé)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rhinosinusitis Chronic

Clinical Trials on Osteopathic manipulative treatment

3
Subscribe